Interesting Neuro: migraine drugs & stroke risks

Our Feb. news & research include two new migraine drugs, the stroke-Parkinson link, and the potential of an anticancer drug to prevent Alzheimer.

We present a selection of interesting neurology articles for the month of February in the following slides. See the slide legends for links to the article summaries.

Related Videos
Related Content

SYMBYX Neuro Light Therapy Wellness Helmet Positively Impacts Parkinson Disease Symptoms

March 25th 2023

Episode 84: Parkinson Disease Education for Community Providers

March 10th 2023

FDA Issues Complete Response Letter for AbbVie’s 24-Hour Continuous Carbidopa/Levodopa Pump

March 22nd 2023

Episode 83: The ARISE Study and Using DMTs in RIS

February 24th 2023

Impaired Decision-Making Symptom Significantly Associated in Cerebellar Ataxia

March 18th 2023

NeurologyLive® Friday 5 — March 17, 2023

March 17th 2023

SYMBYX Neuro Light Therapy Wellness Helmet Positively Impacts Parkinson Disease Symptoms

March 25th 2023

Episode 84: Parkinson Disease Education for Community Providers

March 10th 2023

FDA Issues Complete Response Letter for AbbVie’s 24-Hour Continuous Carbidopa/Levodopa Pump

March 22nd 2023

Episode 83: The ARISE Study and Using DMTs in RIS

February 24th 2023

Impaired Decision-Making Symptom Significantly Associated in Cerebellar Ataxia

March 18th 2023

NeurologyLive® Friday 5 — March 17, 2023

March 17th 2023

SYMBYX Neuro Light Therapy Wellness Helmet Positively Impacts Parkinson Disease Symptoms

March 25th 2023

Episode 84: Parkinson Disease Education for Community Providers

March 10th 2023

FDA Issues Complete Response Letter for AbbVie’s 24-Hour Continuous Carbidopa/Levodopa Pump

March 22nd 2023

Episode 83: The ARISE Study and Using DMTs in RIS

February 24th 2023

Impaired Decision-Making Symptom Significantly Associated in Cerebellar Ataxia

March 18th 2023

NeurologyLive® Friday 5 — March 17, 2023

March 17th 2023
© 2023 MJH Life Sciences

All rights reserved.